These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 29322929)

  • 1. Ontology-based systematic representation and analysis of traditional Chinese drugs against rheumatism.
    Liu Q; Wang J; Zhu Y; He Y
    BMC Syst Biol; 2017 Dec; 11(Suppl 7):130. PubMed ID: 29322929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions.
    Yu H; Nysak S; Garg N; Ong E; Ye X; Zhang X; He Y
    BMC Bioinformatics; 2019 May; 20(Suppl 7):199. PubMed ID: 31074377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China.
    Wang L; Li M; Xie J; Cao Y; Liu H; He Y
    Sci Rep; 2017 Oct; 7(1):13819. PubMed ID: 29061976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events.
    Guo A; Racz R; Hur J; Lin Y; Xiang Z; Zhao L; Rinder J; Jiang G; Zhu Q; He Y
    J Biomed Semantics; 2016; 7():29. PubMed ID: 27213033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic sub-ontology evolution for traditional Chinese medicine web ontology.
    Mao Y; Wu Z; Tian W; Jiang X; Cheung WK
    J Biomed Inform; 2008 Oct; 41(5):790-805. PubMed ID: 18585095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCDO: A Community-Based Ontology for Integrative Representation and Analysis of Traditional Chinese Drugs and Their Properties.
    Zhu Y; Liu L; Gao B; Liu J; Qiao X; Lian C; He Y
    Evid Based Complement Alternat Med; 2021; 2021():6637810. PubMed ID: 34603473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards precision informatics of pharmacovigilance: OAE-CTCAE mapping and OAE-based representation and analysis of adverse events in patients treated with cancer drugs.
    Wong MU; Racz R; Ong E; He Y
    AMIA Annu Symp Proc; 2017; 2017():1793-1801. PubMed ID: 29854250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs.
    Hur J; Özgür A; He Y
    J Biomed Semantics; 2018 Jun; 9(1):17. PubMed ID: 29880031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontology of clinical practice guidelines for Integrated Traditional Chinese and Western Medicine.
    Wang Y; Ren X; Gao K; Chen M; Huang Q; Yan S; Zhu Y; Sun X; Chen Y; Ge L; Gu J; Gao F; Hu W; Hong L; Zhao C; Shang H; Jin Y
    J Evid Based Med; 2024 Sep; 17(3):604-614. PubMed ID: 39238154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicrO: an ontology of phenotypic and metabolic characters, assays, and culture media found in prokaryotic taxonomic descriptions.
    Blank CE; Cui H; Moore LR; Walls RL
    J Biomed Semantics; 2016; 7():18. PubMed ID: 27076900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expert2OWL: A Methodology for Pattern-Based Ontology Development.
    Tahar K; Xu J; Herre H
    Stud Health Technol Inform; 2017; 243():165-169. PubMed ID: 28883193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontology-Based Vaccine Adverse Event Representation and Analysis.
    Xie J; He Y
    Adv Exp Med Biol; 2017; 1028():89-103. PubMed ID: 29058218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OPA2Vec: combining formal and informal content of biomedical ontologies to improve similarity-based prediction.
    Smaili FZ; Gao X; Hoehndorf R
    Bioinformatics; 2019 Jun; 35(12):2133-2140. PubMed ID: 30407490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ontological framework for the formalization, organization and usage of TCM-Knowledge.
    Long H; Zhu Y; Jia L; Gao B; Liu J; Liu L; Herre H
    BMC Med Inform Decis Mak; 2019 Apr; 19(Suppl 2):53. PubMed ID: 30961578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traditional Chinese Medicine (TCM) Domain Ontology: Current Status and Rethinking for the Future Development.
    Zhu Y; Yao KY; Peng SY; Yang XL
    Chin Med Sci J; 2022 Sep; 37(3):228-233. PubMed ID: 36321178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease Specific Ontology of Adverse Events: Ontology extension and adaptation for Chronic Kidney Disease.
    Kang Y; Fink JC; Doerfler R; Zhou L
    Comput Biol Med; 2018 Oct; 101():210-217. PubMed ID: 30195820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a view-oriented approach for aligning RDF-based biomedical repositories.
    Anguita A; García-Remesal M; de la Iglesia D; Graf N; Maojo V
    Methods Inf Med; 2015; 54(1):50-5. PubMed ID: 24777240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated ontology generation framework powered by linked biomedical ontologies for disease-drug domain.
    Alobaidi M; Malik KM; Hussain M
    Comput Methods Programs Biomed; 2018 Oct; 165():117-128. PubMed ID: 30337066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontology-based Vaccine and Drug Adverse Event Representation and Theory-guided Systematic Causal Network Analysis toward Integrative Pharmacovigilance Research.
    He Y
    Curr Pharmacol Rep; 2016 Jun; 2(3):113-128. PubMed ID: 27458549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BiNChE: a web tool and library for chemical enrichment analysis based on the ChEBI ontology.
    Moreno P; Beisken S; Harsha B; Muthukrishnan V; Tudose I; Dekker A; Dornfeldt S; Taruttis F; Grosse I; Hastings J; Neumann S; Steinbeck C
    BMC Bioinformatics; 2015 Feb; 16(1):56. PubMed ID: 25879798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.